Budget Drug and Wellness Center; Declaratory Order Terminating Registration, 17515-17516 [E9-8617]
Download as PDF
Federal Register / Vol. 74, No. 71 / Wednesday, April 15, 2009 / Notices
Written Submissions
As provided in sections 201.8 and
207.15 of the Commission’s rules, any
person may submit to the Commission
on or before May 4, 2009, a written brief
containing information and arguments
pertinent to the subject matter of the
investigations. Parties may file written
testimony in connection with their
presentation at the conference no later
than three days before the conference. If
briefs or written testimony contain BPI,
they must conform with the
requirements of sections 201.6, 207.3,
and 207.7 of the Commission’s rules.
The Commission’s rules do not
authorize filing of submissions with the
Secretary by facsimile or electronic
means, except to the extent permitted by
section 201.8 of the Commission’s rules,
as amended, 67 FR 68036 (November 8,
2002). Even where electronic filing of a
document is permitted, certain
documents must also be filed in paper
form, as specified in II (C) of the
Commission’s Handbook on Electronic
Filing Procedures, 67 FR 68168, 68173
(November 8, 2002).
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the investigation must
be served on all other parties to the
investigations (as identified by either
the public or BPI service list), and a
certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Authority: These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.12 of the
Commission’s rules.
Issued: April 8, 2009.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E9–8507 Filed 4–14–09; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–09–012]
rwilkins on PROD1PC63 with PROPOSALS
Government In the Sunshine Act
Meeting Notice
AGENCY HOLDING THE MEETING: United
States International Trade Commission.
TIME AND DATE: April 23, 2009 at 11 a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agenda for future meetings: none.
VerDate Nov<24>2008
16:44 Apr 14, 2009
Jkt 217001
2. Minutes.
3. Ratification List.
4. Inv. No. 731–TA–1149
(Final)(Circular Welded Carbon Quality
Steel Line Pipe from China)—briefing
and vote. (The Commission is currently
scheduled to transmit its determination
and Commissioners’ opinions to the
Secretary of Commerce on or before May
6, 2009.)
5. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission:
Issued: April 13, 2009.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E9–8744 Filed 4–13–09; 4:15 pm]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Consent Decree
Under the Clean Water Act (CWA)
Notice is hereby given that on March
31, 2009, a proposed Consent Decree in
the case of U.S. v. City of Independence,
Missouri, Civil Action No. 4:09–cv–
00240–DGK, was lodged with the
United States District Court for the
Western District of Missouri.
The United States filed a complaint
concurrently with the Consent Decree
alleging that on numerous occasions the
City of Independence illegally
discharged pollutants, including
wastewater containing raw sewage, from
its sanitary sewer system into waters of
the United States in violation of Section
301 of the CWA, 33 U.S.C. 1311. Under
the Consent Decree, Independence will
pay a civil penalty of $255,000 and be
required to perform a comprehensive
assessment of the sanitary sewer system,
upgrade its pump stations, and
implement improvements to its
wastewater collection system and
wastewater treatment plant.
Independence will also perform
supplemental environmental projects
valued at $450,000. The environmental
projects are designed to enhance water
quality within the Missouri River
watershed by improving storm water
detention basins and stabilizing stream
banks.
For thirty (30) days after the date of
this publication, the Department of
Justice will receive comments relating to
the Consent Decree. Comments should
be addressed to the Acting Assistant
Attorney General, Environment and
Natural Resources Division, and either
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
17515
e-mailed to pubcommentees.enrd@usdoj.gov or mailed to P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611. In either
case, the comments should refer to U.S.
v. City of Independence, Missouri, D.J.
Ref. No. 90–5–1–1–08702.
During the comment period, the
Consent Decree may be examined on the
following Department of Justice Web
site: https://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
Consent Decree may also be obtained by
mail from the Consent Decree Library,
P.O. Box 7611, U.S. Department of
Justice, Washington, DC 20044–7611, or
by faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax No. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $10.00 (25 cents per
page reproduction cost) payable to the
United States Treasury or, if by e-mail
or fax, forward a check in that amount
to the Consent Decree Library at the
stated address.
Maureen Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. E9–8570 Filed 4–14–09; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 06–11]
Budget Drug and Wellness Center;
Declaratory Order Terminating
Registration
On August 24, 2005, I, the Deputy
Administrator of the Drug Enforcement
Administration, issued an Order to
Show Cause to Budget Drug and
Wellness Center (Respondent), of
Feasterville, Pennsylvania.1 The Show
Cause Order proposed the revocation of
Respondent’s DEA Certificate of
Registration, BB5209223, which
authorizes it to dispense controlled
substances as a retail pharmacy, and the
denial of any pending applications to
renew or modify its registration, on the
ground that it had committed acts
which render its registration
inconsistent with the public interest.
ALJ Ex. 1.
As grounds for the proceeding, the
Show Cause Order alleged, inter alia,
1 Upon the commencement of the proceeding, I
also immediately suspended Respondent’s
registration. On April 12, 2006, the suspension
order was withdrawn.
E:\FR\FM\15APN1.SGM
15APN1
rwilkins on PROD1PC63 with PROPOSALS
17516
Federal Register / Vol. 74, No. 71 / Wednesday, April 15, 2009 / Notices
that Respondent had violated its
corresponding responsibility under
Federal law by filling prescriptions
which were not issued for a legitimate
medical purpose by a practitioner acting
in the usual course of professional
practice. Id. More specifically, the Order
alleged that Respondent had ‘‘acquired
over 15 million dosage units of’’ such
drugs as Didrex and phentermine,
which are schedule III and IV controlled
substances respectively, and that
Respondent was dispensing ‘‘huge
amounts of dosage units to persons
who’’ obtained prescriptions through
the Internet and ‘‘who [were] never
actually seen or examined by a
physician.’’ Id. at 8.
Respondent timely requested a
hearing. The matter was placed on the
docket of the Agency’s Administrative
Law Judges (ALJ), and a hearing was
held on March 27 through 29, 2006, at
which both parties elicited the
testimony of witnesses and introduced
various documents into evidence.
Following the hearing, both parties
submitted briefs containing their
proposed findings of fact, conclusions of
law, and argument. Moreover, on
October 11, 2007, the ALJ invited the
parties to submit additional briefs in
light of my decision in United
Prescription Services, Inc., 72 FR 50397
(2007); both parties did so.
Thereafter, on March 10, 2008, the
ALJ issued her recommended decision.
In her decision, the ALJ found that
Respondent and its owner had
repeatedly violated Federal law by
filling prescriptions for controlled
substances which it had reason to know
were unlawful. ALJ at 64–69. The ALJ
also found that Respondent’s owner had
failed to accept responsibility for her
misconduct. Id. at 70. The ALJ thus
concluded that ‘‘Respondent’s
continued registration would be
inconsistent with the public interest,’’
and recommended that I revoke its
registration and deny any pending
applications. Id.
On May 2, 2008, Respondent filed
exceptions to the ALJ decision. Shortly
thereafter, the record was forwarded to
me for final agency action.
During the course of reviewing the
record, my office determined that on
August 12, 2008, Respondent had been
acquired by Walgreens. On the same
day, Respondent also surrendered its
registration certificate, as well as its
order forms (DEA Form 222), to the
Agency’s Philadelphia Field Division
Office. Letter of Charlotte J. Lopacki,
R.Ph., to DEA Philadelphia Field Div.
Office (August 12, 2008). There is,
however, no evidence that Respondent
completed a voluntary surrender form.
VerDate Nov<24>2008
16:44 Apr 14, 2009
Jkt 217001
Based on these acts, I find that
Respondent has discontinued business.
Under 21 CFR 1301.52(a), ‘‘the
registration of any person shall
terminate if and when such person
* * * discontinues business or
professional practice.’’ Accordingly, I
will declare that Respondent’s
registration has terminated with an
effective date of August 12, 2008. And
because there are no pending
applications before the Agency, I further
hold that the Show Cause proceeding is
now moot.2
Order
Pursuant to the authority vested in me
under 5 U.S.C. 554(e), as well as 28 CFR
0.100(b) & 0.104, I hereby declare
terminated as of August 12, 2008, DEA
Certificate of Registration, BB5209223,
issued to Budget Pharmacy and
Wellness Center, of Feasterville,
Pennsylvania. Pursuant to the authority
vested in me by 21 U.S.C. 823(f) &
824(a), as well as 28 CFR 0.100(b) &
0.104, I further order that the Order to
Show Cause issued to Budget Pharmacy
and Wellness Center be, and it hereby
is, dismissed. This Order is effective
immediately.
Dated: April 3, 2009.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E9–8617 Filed 4–14–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 08–50]
Sylvester A. Nathan; Dismissal of
Proceeding
On June 25, 2008, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Sylvester A. Nathan,
M.D. (Respondent), of Woodridge,
Illinois. The Show Cause Order
proposed the revocation of
Respondent’s DEA Certificate of
Registration, AN1430343, which
authorized him to dispense controlled
substances as a practitioner, and the
denial of any pending applications to
renew or modify the registration, on the
ground that the Illinois Department of
Professional Regulation had suspended
2 While I have raised the issue of Respondent’s
registration status sua sponte, in the event
Respondent seeks to refute the factual basis upon
which I rely, it may do so by filing a motion for
reconsideration within fifteen days of the date of
service of this Order, which shall begin on the date
the Order is mailed.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Respondent’s ‘‘state license to handle
controlled substances,’’ and that
Respondent is therefore without
authority to dispense controlled
substances in the State in which he
holds his registration. Id. at 1.
Respondent timely requested a
hearing on the allegations and sought a
five-month long continuance of the
proceeding. Thereafter, the Government
moved to deny Respondent’s request for
a continuance and for summary
disposition. The basis for the summary
disposition motion was that
Respondent’s state medical license had
been suspended. As support for the
motion, the Government attached: (1) A
copy of a July 25, 2007 order of the
Illinois Department of Financial and
Professional Regulation (IDFPR), which
indefinitely suspended Respondent’s
Illinois Physician and Surgeon’s
Certificate until he provided proof that
he has passed the Special Purpose
Examination (SPEX); and (2) a July 8,
2008 printout of Respondent’s Physician
Profile from the IDFPR’s Web site,
which indicated that the status of
Respondent’s license was ‘‘suspended.’’
Thereafter, the ALJ issued an Order
for Respondent’s Response. On August
11, 2008, Respondent submitted his
response in which he acknowledged
that since July 25, 2007, he ‘‘has no
authority to prescribe, handle or
[d]ispense any [c]ontrolled medical
substances in the state’’ of Illinois. With
the submission, Respondent also
enclosed his DEA Certificate of
Registration but indicated on the
document that it was being ‘‘returned
under protest.’’
Shortly thereafter, the ALJ granted the
Government’s motion for summary
disposition. ALJ at 6. The ALJ noted that
there was no dispute that ‘‘Respondent
is not authorized to practice medicine in
Illinois’’ and thus could not ‘‘prescribe
controlled substance in that State.’’ Id.
at 5. Applying the Agency’s
longstanding interpretation that the
Controlled Substances Act precludes the
continuation of a registration if the
practitioner no longer holds authority to
dispense controlled substances in the
State in which he practices medicine,
id. (collecting cases); the ALJ granted
the Government’s motion and
recommended that Respondent’s
registration be revoked and that any
pending application be denied.
Respondent did not file exceptions to
the ALJ’s decision. On September 11,
2008, the record was forwarded to me
for final agency action. Having
considered the entire record and having
taken official notice of the registration
E:\FR\FM\15APN1.SGM
15APN1
Agencies
[Federal Register Volume 74, Number 71 (Wednesday, April 15, 2009)]
[Notices]
[Pages 17515-17516]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8617]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 06-11]
Budget Drug and Wellness Center; Declaratory Order Terminating
Registration
On August 24, 2005, I, the Deputy Administrator of the Drug
Enforcement Administration, issued an Order to Show Cause to Budget
Drug and Wellness Center (Respondent), of Feasterville,
Pennsylvania.\1\ The Show Cause Order proposed the revocation of
Respondent's DEA Certificate of Registration, BB5209223, which
authorizes it to dispense controlled substances as a retail pharmacy,
and the denial of any pending applications to renew or modify its
registration, on the ground that it had committed acts which render its
registration inconsistent with the public interest. ALJ Ex. 1.
---------------------------------------------------------------------------
\1\ Upon the commencement of the proceeding, I also immediately
suspended Respondent's registration. On April 12, 2006, the
suspension order was withdrawn.
---------------------------------------------------------------------------
As grounds for the proceeding, the Show Cause Order alleged, inter
alia,
[[Page 17516]]
that Respondent had violated its corresponding responsibility under
Federal law by filling prescriptions which were not issued for a
legitimate medical purpose by a practitioner acting in the usual course
of professional practice. Id. More specifically, the Order alleged that
Respondent had ``acquired over 15 million dosage units of'' such drugs
as Didrex and phentermine, which are schedule III and IV controlled
substances respectively, and that Respondent was dispensing ``huge
amounts of dosage units to persons who'' obtained prescriptions through
the Internet and ``who [were] never actually seen or examined by a
physician.'' Id. at 8.
Respondent timely requested a hearing. The matter was placed on the
docket of the Agency's Administrative Law Judges (ALJ), and a hearing
was held on March 27 through 29, 2006, at which both parties elicited
the testimony of witnesses and introduced various documents into
evidence. Following the hearing, both parties submitted briefs
containing their proposed findings of fact, conclusions of law, and
argument. Moreover, on October 11, 2007, the ALJ invited the parties to
submit additional briefs in light of my decision in United Prescription
Services, Inc., 72 FR 50397 (2007); both parties did so.
Thereafter, on March 10, 2008, the ALJ issued her recommended
decision. In her decision, the ALJ found that Respondent and its owner
had repeatedly violated Federal law by filling prescriptions for
controlled substances which it had reason to know were unlawful. ALJ at
64-69. The ALJ also found that Respondent's owner had failed to accept
responsibility for her misconduct. Id. at 70. The ALJ thus concluded
that ``Respondent's continued registration would be inconsistent with
the public interest,'' and recommended that I revoke its registration
and deny any pending applications. Id.
On May 2, 2008, Respondent filed exceptions to the ALJ decision.
Shortly thereafter, the record was forwarded to me for final agency
action.
During the course of reviewing the record, my office determined
that on August 12, 2008, Respondent had been acquired by Walgreens. On
the same day, Respondent also surrendered its registration certificate,
as well as its order forms (DEA Form 222), to the Agency's Philadelphia
Field Division Office. Letter of Charlotte J. Lopacki, R.Ph., to DEA
Philadelphia Field Div. Office (August 12, 2008). There is, however, no
evidence that Respondent completed a voluntary surrender form.
Based on these acts, I find that Respondent has discontinued
business. Under 21 CFR 1301.52(a), ``the registration of any person
shall terminate if and when such person * * * discontinues business or
professional practice.'' Accordingly, I will declare that Respondent's
registration has terminated with an effective date of August 12, 2008.
And because there are no pending applications before the Agency, I
further hold that the Show Cause proceeding is now moot.\2\
---------------------------------------------------------------------------
\2\ While I have raised the issue of Respondent's registration
status sua sponte, in the event Respondent seeks to refute the
factual basis upon which I rely, it may do so by filing a motion for
reconsideration within fifteen days of the date of service of this
Order, which shall begin on the date the Order is mailed.
---------------------------------------------------------------------------
Order
Pursuant to the authority vested in me under 5 U.S.C. 554(e), as
well as 28 CFR 0.100(b) & 0.104, I hereby declare terminated as of
August 12, 2008, DEA Certificate of Registration, BB5209223, issued to
Budget Pharmacy and Wellness Center, of Feasterville, Pennsylvania.
Pursuant to the authority vested in me by 21 U.S.C. 823(f) & 824(a), as
well as 28 CFR 0.100(b) & 0.104, I further order that the Order to Show
Cause issued to Budget Pharmacy and Wellness Center be, and it hereby
is, dismissed. This Order is effective immediately.
Dated: April 3, 2009.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E9-8617 Filed 4-14-09; 8:45 am]
BILLING CODE 4410-09-P